A pharmaceutical company that develops topical eye drops for the treatment of eye diseases
Panoptica is a company operating in the biomedical engineering, biotechnology, technology, and biology industries. The company is based in Mount Arlington, New Jersey, United States, and its full address is 13 McGregor Avenue Mount Arlington, NJ 07856. Panoptica is an organization and has been classified as a company.
As of June 10, 2017, Panoptica has raised a total of $52,000,000 in funding through its last funding type, the Series B round. Investors in the company include Third Rock Ventures and SV Health Investors. Panoptica has been assigned four patents.